DEF 14AThe Ballot
Niagen Bioscience, Inc. files DEF 14A
Filed Apr 12, 2016 · 10y ago · Accession 0001415889-16-005497
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Niagen Bioscience, Inc.
- Ticker
- NAGE
- CIK
- 1386570
- Form type
- DEF 14A
- Filing date
- Apr 12, 2016
- Report date
- Jun 2, 2016
- Document
- cdxcdef14a_jun22016.htm
- Size
- 741 KB